Screener
Olema Pharmaceuticals, Inc. OLMA Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218156
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025; no shares issued and outstanding as of March 31, 2026 and December 31, 2025. | — | — |
| Common stock, $0.0001 par value; 490,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 87,332,971 and 81,376,449 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively. | 8 | 8 |
| Additional paid-in capital | 1,131,576 | 1,075,487 |
| Accumulated other comprehensive (loss) income | (460) | 621 |
| Accumulated deficit | (650,646) | (597,557) |
| Total stockholders’ equity | 480,478 | 478,559 |
| Total liabilities and stockholders’ equity | $530,645 | $533,430 |
Item 1. Financial Statements.
FAQ
- What is Olema Pharmaceuticals, Inc.'s retained earnings?
- Olema Pharmaceuticals, Inc. (OLMA) reported retained earnings of -$650.65M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s retained earnings changed year-over-year?
- Olema Pharmaceuticals, Inc.'s retained earnings decreased by 39.8% year-over-year, from -$465.5M to -$650.65M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Olema Pharmaceuticals, Inc.'s retained earnings has grown at a 78.4% compound annual growth rate (CAGR), from -$33.09M to -$597.56M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Olema Pharmaceuticals, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude